Iindaba - Yintoni ekufuneka abavelisi bayazi malunga nomgubo we-Alpha Lipoic Acid?

Yintoni kanye kanye i-Alpha Lipoic Acid Powder?

I-Alpha Lipoic Acid (ALA) yikhompawundi yendalo edlala indima ebalulekileyo emzimbeni womntu. Isebenza njenge-coenzyme kwiimpendulo ezininzi ze-mitochondrial, ezinoxanduva lokuvelisa amandla eeseli. Ngokungafaniyo nezinye izondlo ezilinganiselwe kwiindawo ezithile, i-ALA ikhona kwiseli nganye, nto leyo eyenza ibaluleke kakhulu ekugcineni umsebenzi ofanelekileyo we-metabolic.

Ngokwembono yokuvelisa, umgubo we-ALA uveliswa ngeendlela eziphambili zokukhupha kunye nokudibanisa ukuqinisekisa ubunyulu obuphezulu kunye nokufumaneka kwezinto eziphilayo. Ihlala inikezelwa njengomgubo ocolekileyo, otyheli okhanyayo, okulula ukuwubumba ube ziikhaphukhaphu, iipilisi, iipowders zokusela, okanye nokuba zizinto zokutya okulula. Olu kuguquguquka sesinye sezizathu zokuba i-ALA ibe sisithako esithandwayo phakathi kweemveliso zezongezo.

Kutheni i-Alpha Lipoic Acid ibizwa ngokuba yi-"Universal Antioxidant"?

Igama lesidlaliso le-ALA, elithi “universal antioxidant,” livela kubuchule bayo obukhethekileyo bokusebenza kwiindawo ezinyibilikayo emanzini nakwindawo ezinyibilikayo ngamafutha. Oku kuthetha ukuba inokuhamba emzimbeni wonke, kuquka nakwi-membranes yeseli, ukuze inciphise ii-free radicals eziyingozi naphi na apho zivela khona.

Ukongeza, i-ALA ayisebenzi yodwa — inamandla angaqhelekanga okuphinda isebenzise ezinye ii-antioxidants. Umzekelo, xa iVithamin C okanye iVithamin E isetyenziswa ngokupheleleyo kwinkqubo yokulwa noxinzelelo lwe-oxidative, i-ALA inokunceda ukuyibuyisela kwimo yayo esebenzayo. Le propati yokuvuselela iphucula ukusebenza kwenethiwekhi epheleleyo ye-antioxidant kwaye inika abavelisi ibango eliqinileyo elixhaswa yisayensi xa bekhuthaza iimveliso ezine-ALA.

I-ALA ixhasa njani imveliso yamandla?

Indima ephambili ye-Alpha Lipoic Acid ekuveliseni amandla kukunceda ii-enzymes ziqhekeze ii-carbohydrate zibe ngamandla asebenzisekayo. Ngokukodwa, isebenza njenge-cofactor yee-enzyme complexes ze-mitochondrial eziguqula i-glucose ibe yi-ATP - imali yamandla yeeseli.

Kubathengi, oku kuthetha ukuba i-metabolism yamandla isebenza kakuhle kwaye inciphise ukudinwa, ingakumbi kwabo baphila ubomi obuxakekileyo. Kubavelisi, oku kuthetha ukuba i-ALA inokubekwa njengesisombululo sendalo sokuxhasa amandla kwizongezo ezijoliswe kubasebenzi baseofisini, abafundi, kunye nabantu abakhutheleyo. Indima yayo ephindwe kabini njenge-energy booster kunye ne-antioxidant yenza ukuba ibe lukhetho olunomtsalane kwiifomyula ezininzi.

Ngaba i-ALA inokunceda ekulawuleni amanqanaba eswekile egazini asempilweni?

Enye yezona nzuzo ziphandwe kakhulu ze-ALA yimpembelelo yayo kwi-metabolism yeglucose. Iphucula uvakalelo lwe-insulin, inceda umzimba ukuba usebenzise iglucose ngokufanelekileyo. Oku kubangela ukuba amanqanaba amandla azinzile imini yonke kwaye kungabi naxinzelelo kwi-pancreas.

Kubavelisi, oku kuvula amathuba okuthengisa i-ALA njengenxalenye yeemveliso zokuxhasa iswekile yegazi, ii-metabolic health complexes, okanye izongezo zokwaluphala ezisempilweni. Ezi ziindidi ezifunwa kakhulu njengoko abathengi besiya beqonda ngakumbi ukubaluleka kokugcina amanqanaba eswekile egazini asempilweni ukuthintela ukudinwa kunye neengxaki zexesha elide.

Kutheni i-ALA idumile kwiifomyula zokulwa nokuguga?

Uxinzelelo lwe-oxidative yenye yezona zinto zibangela ukwaluphala kweeseli. Ngokuhamba kwexesha, umonakalo we-free radicals unokuqokelelana kwaye uchaphazele kakubi ukuqina kwesikhumba, impilo yengqondo, kunye namandla ayo onke. I-ALA ilwa noku ngokukhusela iiseli ekulimaleni kwe-oxidative kwaye ikwaxhasa ukuvuselelwa kwezinye ii-antioxidants.

Abavelisi abaninzi benza i-ALA ibe ziimveliso ezithengiswa njenge "anti-aging from inside." Ezi zongezo zinomtsalane kubathengi abafuna isisombululo esipheleleyo esixhasa ukukhanya kolusu, impilo yengqondo, kunye namanqanaba amandla ngaxeshanye. Le nzuzo ijolise kwizinto ezininzi yindawo enamandla yokuthengisa kwimarike yobuhle kunye nempilo-ntle ekhuphisanayo.

Yintoni eyenza i-Alpha Lipoic Acid ibe yodwa xa ithelekiswa nezinye ii-antioxidants?

Uninzi lwee-antioxidants zinyibilika emanzini okanye zinyibilika ngamafutha, oko kuthetha ukuba zinqongophele apho zinokusebenza khona emzimbeni. Ukunyibilika kabini kwe-ALA kuyinika inzuzo ekhethekileyo, okuyivumela ukuba isebenze kwiindawo zangaphakathi kweseli kunye nezangaphandle.

Le propati ikhethekileyo ikwavumela i-ALA ukuba idlule umqobo wegazi-ubuchopho, yiyo loo nto idla ngokubandakanywa kwiifomyula zokuxhasa ingqondo. Kubavelisi, olu luhlu olubanzi lomsebenzi luthetha ukuba i-ALA inokukhuthazwa kwiindidi ezahlukeneyo - ukusuka kwimpilo ye-metabolic ukuya kwimpilo yengqondo ukuya kwimpilo yolusu - ngaphandle kokufuna izithako ezahlukeneyo kumsebenzi ngamnye.

Ngaba i-ALA ifanelekile kumaqela amaninzi abathengi?

Enye yezona nzuzo zinkulu ze-ALA kukuba inomtsalane omkhulu. Iingcali eziselula zingayisebenzisa ukuze zinike amandla kunye nokucaca kwengqondo, abadlali banokuyixabisa ukuze baphile ngcono, kwaye abantu abadala banokuyithatha ukuze ixhase imetabolism kunye nengqondo.

Olu luhlu olubanzi lwezicelo luyenza ibe sisithako esiguquguqukayo kubavelisi, nto leyo ebavumela ukuba baphuhlise ii-SKU ezininzi ezijolise kwiindidi ezahlukeneyo zabantu - ukusuka kwisondlo sezemidlalo ukuya kwimpilo yabantu abadala - besebenzisa isithako esifanayo esiphambili.

Kutheni Abavelisi Befanele Bakhethe Umthengisi we-ALA Othembekileyo?

Ngenxa yokuba i-ALA inovelwano kubushushu, ukukhanya, kunye ne-pH, umgangatho wayo unokonakala ngokulula ngaphandle kokuphathwa ngokufanelekileyo. Yingakho ukukhetha umthengisi onobuchwepheshe bemveliso obuphambili kunye nolawulo lomgangatho oluqinileyo kubalulekile.

Abavelisi kufuneka bajonge ababoneleli ababonelela ngedatha yovavanyo lomntu wesithathu (efana ne-HPLC, i-GC, kunye nohlalutyo lwe-microbiological) ukuqinisekisa ubunyulu kunye namandla emveliso. Oku akugcini nje ngokukhusela udumo lophawu kodwa kwakha ukuthembana nabathengi bokugqibela abafuna ngakumbi ukucaca kwizongezo abazithengayo.

Ukuvalwa kwesitayile sokuThengisa

Umgubo we-Alpha Lipoic Acid ungaphezulu nje kwesithako esithandwayo - sisisombululo esixhaswa yisayensi samandla, impilo ye-metabolic, kunye nokulwa nokwaluphala. Nokuba wenza i-capsule yezithako esinye okanye umxube ontsonkothileyo wezibonelelo zempilo eziphambili, i-ALA inokukunceda ubonakale kwimarike enabantu abaninzi.

Ngokubambisana nomthengisi oqinisekisa umgangatho ohambelanayo, amaxabiso akhuphisanayo, kunye nokuhanjiswa okuthembekileyo, ungaqalisa ngokuzithemba iimveliso ezihlangabezana neemfuno zabathengi bakho — kwaye ubagcine bebuya ukuze bafumane okungakumbi.

Isalathiso
UBiewenga, GP, uHaenen, GR, kunye noBast, A. (1997). I-pharmacology ye-antioxidant lipoic acid. I-General Pharmacology: Inkqubo yeMithambo, 29(3), 315-331. https://doi.org/10.1016/S0306-3623(96)00474-0
Packer, L., Witt, EH, kunye noTritschler, HJ (1995). I-Alpha-lipoic acid njenge-antioxidant yebhayoloji. I-Free Radical Biology and Medicine, 19(2), 227-250. https://doi.org/10.1016/0891-5849(95)00017-R

Shay, KP, Moreau, RF, Smith, EJ, Smith, AR, kunye noHagen, TM (2009). I-Alpha-lipoic acid njengesongezelelo sokutya: Iindlela zeMolekyuli kunye nobuchule bonyango. Biochimica et Biophysica Acta (BBA) - Izifundo eziQhelekileyo, 1790(10), 1149-1160. https://doi.org/10.1016/j.bbagen.2009.07.026

UGomes, MB, kunye noNegrato, CA (2014). I-Alpha-lipoic acid njengekhompawundi ye-pleiotropic enokusetyenziswa kunyango kwisifo seswekile kunye nezinye izifo ezingapheliyo. I-Diabetology & Metabolic Syndrome, 6(1), 80. https://doi.org/10.1186/1758-5996-6-80

Rochette, L., Ghibu, S., Richard, C., Zeller, M., Cottin, Y., kunye noVergely, C. (2013). Iipropati ze-antioxidant ezithe ngqo nezingathanga ngqo ze-alpha-lipoic acid kunye nobuchule bonyango. I-Molecular Nutrition & Food Research, 57(1), 114-125. https://doi.org/10.1002/mnfr.201200608

UZiegler, D., uReljanovic, M., uMehnert, H., kunye noGries, FA (1999). I-Alpha-lipoic acid kunyango lwe-diabetes polyneuropathy eJamani: Ubungqina bangoku obuvela kuvavanyo lweklinikhi. I-Experimental and Clinical Endocrinology & Diabetes, 107(7), 421-430. https://doi.org/10.1055/s-0029-1212120

Liu, J. (2008). Iziphumo kunye neendlela ze-alpha-lipoic acid yezakhamzimba ze-mitochondrial ekuphuculeni ukungasebenzi kakuhle kwe-mitochondrial kunye nengqondo enxulumene nobudala: Isishwankathelo. Uphando lweNeurochemical, 33(1), 194-203. https://doi.org/10.1007/s11064-007-9479-8